0001237899-15-000011.txt : 20150105 0001237899-15-000011.hdr.sgml : 20150105 20150105162841 ACCESSION NUMBER: 0001237899-15-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141231 FILED AS OF DATE: 20150105 DATE AS OF CHANGE: 20150105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9143477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Powchik Peter CENTRAL INDEX KEY: 0001377247 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 15505269 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2014-12-31 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001377247 Powchik Peter 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 SVP Clinical Development & Reg Common Stock 2014-12-31 4 M 0 25000.0 52.03 A 35711 D Common Stock 2014-12-31 4 F 0 3151.0 412.78 D 32560 D Common Stock 2014-12-31 4 F 0 11027.0 412.78 D 21533 D Common Stock 2015-01-02 4 S 0 1400.0 410.99 D 20133 D Common Stock 2015-01-02 4 S 0 1122.0 411.99 D 19011 D Common Stock 2015-01-02 4 S 0 1700.0 412.81 D 17311 D Common Stock 2015-01-02 4 S 0 2758.0 414.07 D 14553 D Common Stock 2015-01-02 4 S 0 1642.0 415.2 D 12911 D Common Stock 2015-01-02 4 S 0 900.0 416.75 D 12011 D Common Stock 2015-01-02 4 S 0 1000.0 417.44 D 11011 D Common Stock 2015-01-02 4 S 0 300.0 418.4 D 10711 D Common Stock 18000 I by GRAT Common Stock 1621 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 52.03 2014-12-31 4 M 0 25000.0 0.0 D 2021-12-16 Common Stock 25000 37079 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 1,400 shares of Company stock on January 2, 2015 at prices ranging from $410.48 to $411.36. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2015 at each separate price. Represents volume-weighted average price of sales of 1,122 shares of Company stock on January 2, 2015 at prices ranging from $411.53 to $412.44. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2015 at each separate price. Represents volume-weighted average price of sales of 1,700 shares of Company stock on January 2, 2015 at prices ranging from $412.58 to $413.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2015 at each separate price. Represents volume-weighted average price of sales of 2,758 shares of Company stock on January 2, 2015 at prices ranging from $413.75 to $414.56. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2015 at each separate price. Represents volume-weighted average price of sales of 1,642 shares of Company stock on January 2, 2015 at prices ranging from $414.97 to $415.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2015 at each separate price. Represents volume-weighted average price of sales of 900 shares of Company stock on January 2, 2015 at prices ranging from $416.00 to $416.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2015 at each separate price. Represents volume-weighted average price of sales of 1,000 shares of Company stock on January 2, 2015 at prices ranging from $417.03 to $417.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2015 at each separate price. Represents volume-weighted average price of sales of 300 shares of Company stock on January 2, 2015 at prices ranging from $418.16 to $418.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2015 at each separate price. The option became exercisable with respect to all shares underlying the option on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014. /s/**Peter Powchik 2015-01-03